[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336390-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336390-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cd248-expressing-cancer-associated-fibroblasts-induce-epithelialmesenchymal-transition-of-non-small-cell-lung-cancer-via-inducing-m2-polarized-macrophages","CD248-expressing cancer-associated fibroblasts induce epithelial–mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages","","Non-small cell lung cancer (NSCLC) progression is driven by cancer-associated fibroblasts (CAFs) that regulate immune interactions. CD248-expressing CAFs were previously shown to activate M2-polarized macrophages, but the mechanism linking this polarization to the EMT program in NSCLC cells remained unclear. This study assessed CD248 expression in CAFs from NSCLC patient tumor tissues, evaluated macrophage polarization after CD248 knockdown, and tested the impact of CD248-harboring CAFs on EMT in vitro and in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cd248-expressing-cancer-associated-fibroblasts-induce-epithelialmesenchymal-transition-of-non-small-cell-lung-cancer-via-inducing-m2-polarized-macrophages/336390/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cd248-expressing-cancer-associated-fibroblasts-induce-epithelialmesenchymal-transition-of-non-small-cell-lung-cancer-via-inducing-m2-polarized-macrophages/336390.png","ImageObject",300,407,{"name":42,"@type":43},"Violet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main relationship proposed between CD248+ CAFs and NSCLC EMT?","Question",{"text":63,"@type":64},"CD248+ cancer-associated fibroblasts promote epithelial–mesenchymal transition in NSCLC by regulating macrophages toward an M2-polarized phenotype.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What experimental models were used to test the role of CD248-harboring CAFs?",{"text":68,"@type":64},"The work used in vitro studies assessing macrophage polarization and NSCLC EMT, and it also constructed CD248-specific gene knockout fibroblast models in mice to evaluate the effects in vivo.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the study assess whether CD248 in CAFs influences macrophage polarization?",{"text":72,"@type":64},"It examined CD248 expression in CAFs derived from NSCLC patient tumor tissues and determined the effects of CD248 knockdown in CAFs on macrophage polarization toward the M2 type.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336390,1790194231,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCD248‑expressing cancer‑associated fibroblasts induce epithelial–mesenchymal transition of non‑small cell lung cancer via inducing M2‑polarized macrophages  \nJing Xiao1,8, Zeyang Yang1,8, Siyu Wang1,2,8, Xinlei Liu3, Yun Wang1,3,4, Zuquan Hu4,5, Zhu Zeng1,4,5* & Jieheng Wu1,5,6,7*  \nNon‑small cell lung cancer (NSCLC)‑originating cancer‑associated fibroblasts (CAFs) expressing CD248 regulate interaction with immune cells to accelerate cancer progression. Epithelial–mesenchymal transition (EMT) is a key feature of metastatic cells. In our pervious study, we found that CD248+CAFs activated M2‑polarized macrophages, enhancing the progression of NSCLC. However, it is yet unclear how CD248+CAFs inducing M2‑polarized macrophages induce EMT program in NSCLC cells. Herein, we examined CD248 expression from CAFs derived from NSCLC patient tumour tissues. Furthermore, we determined the influence of CD248 knock down CAFs on macrophages polarization. Next, we explored the influences of CD248‑harboring CAFs‑mediated M2 macrophage polarization to promote NSCLC cells EMT in vitro. We constructed fibroblasts specific CD248 gene knock out mice to examine the significance of CD248‑harboring CAFs‑induced M2‑polarized macrophages to promote NSCLC cells EMT in vivo. Based on our analysis, CD248 is ubiquitously expressed within NSCLC‑originating CAFs. CD248+CAFs mediated macrophages polarized to M2 type macrophages. CD248+CAFs induced M2 macrophage polarization to enhance NSCLC cells EMT both in vivo and in vitro. Our findings indicate that CD248‑harboring CAFs promote NSCLC cells EMT by regulating M2‑polarized macrophages.  \nKeywords CD248, Cancer-associated fibroblasts, Non-small cell lung cancer, M2 macrophages, EMT  \nAbbreviations  \nCAFs Cancer-associated fibroblasts  \nEMT Epithelial–mesenchymal transition NAT Normal adjacent tissues  \n1Department of Immunology, Guizhou Medical University, Siya Road, Guiyang 561113, China. 2College of Stomatology, Guizhou Medical University, Guiyang 561113, China. 3Guizhou Prenatal Diagnosis Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550001, China. 4Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang 561113, China. 5Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences, Guizhou Medical University, Guiyang 561113, China. 6The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi’an 710032, China. 7Tumor Immunotherapy Technology Engineering Research Center of Guizhou Medical University, Guizhou Medical University, Guiyang 561113, China. 8These authors contributed equally: Jing Xiao, Zeyang Yang and Siyu Wang.* email: [zengzhu@gmc.edu.cn](zengzhu@gmc.edu.cn); [immunewjh@163.com](immunewjh@163.com); wujiehen@ [gmc.edu.cn](gmc.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nNC Negative control  \nNFs Normal fibroblasts  \nNSCLC Non-small cell lung cancer STR Short tandem repeat  \nTME Tumour microenvironment  \nLung cancer (LC) is highly prevalent among all cancers. Its prevalence and mortality rates rank second and first, respectively, among all malignant tumors. NSCLC constitutes ~ 80–85% of newly diagnosed LC incidences1. About 75% of NSCLC patients exhibit evidence of regional or distal metastasis, and only 15% of metastatic NSCLC patients live for at least 5 years post diagnosis2,3. Exploring the molecular mechanisms underlying NSCLC progression remains the focus of cancer research.  \nCancer formation is multi-tiered and involves the migration of cancerous cells to distant locations. Among its essential regulations is the","cbCaipkIgZyL0LjF","https://ap.wps.com/l/cbCaipkIgZyL0LjF","pdf",3062777,"English","# Background\n## EMT and metastatic changes in NSCLC\n## Tumor microenvironment and CAF roles\n# CD248 in CAF biology\n# Study aims and experimental approach","[{\"question\":\"What is the main relationship proposed between CD248+ CAFs and NSCLC EMT?\",\"answer\":\"CD248+ cancer-associated fibroblasts promote epithelial–mesenchymal transition in NSCLC by regulating macrophages toward an M2-polarized phenotype.\"},{\"question\":\"What experimental models were used to test the role of CD248-harboring CAFs?\",\"answer\":\"The work used in vitro studies assessing macrophage polarization and NSCLC EMT, and it also constructed CD248-specific gene knockout fibroblast models in mice to evaluate the effects in vivo.\"},{\"question\":\"How did the study assess whether CD248 in CAFs influences macrophage polarization?\",\"answer\":\"It examined CD248 expression in CAFs derived from NSCLC patient tumor tissues and determined the effects of CD248 knockdown in CAFs on macrophage polarization toward the M2 type.\"}]","CD248-expressing cancer-associated fibroblasts induce epithelial–mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages | PDF",1790014825,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d4be92d43981aa680f1c2d941408b79.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7c45328783f84dc14d51f84d824433e.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cf99a605d42c1b344061014b3c2a31b.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b95bf92b973b2b94e3c7439b14ba7c3d.webp",980,1287]